YUANDA_CHINA(2789.HK):A_PAINSTAKING_YEAR_OF_REMEDY_AHEAD;_DOWNGRADING_TO_HOLD-2013-04-19.pdf

上传人:爱问知识人 文档编号:3803360 上传时间:2019-09-23 格式:PDF 页数:22 大小:606.75KB
返回 下载 相关 举报
YUANDA_CHINA(2789.HK):A_PAINSTAKING_YEAR_OF_REMEDY_AHEAD;_DOWNGRADING_TO_HOLD-2013-04-19.pdf_第1页
第1页 / 共22页
YUANDA_CHINA(2789.HK):A_PAINSTAKING_YEAR_OF_REMEDY_AHEAD;_DOWNGRADING_TO_HOLD-2013-04-19.pdf_第2页
第2页 / 共22页
YUANDA_CHINA(2789.HK):A_PAINSTAKING_YEAR_OF_REMEDY_AHEAD;_DOWNGRADING_TO_HOLD-2013-04-19.pdf_第3页
第3页 / 共22页
YUANDA_CHINA(2789.HK):A_PAINSTAKING_YEAR_OF_REMEDY_AHEAD;_DOWNGRADING_TO_HOLD-2013-04-19.pdf_第4页
第4页 / 共22页
YUANDA_CHINA(2789.HK):A_PAINSTAKING_YEAR_OF_REMEDY_AHEAD;_DOWNGRADING_TO_HOLD-2013-04-19.pdf_第5页
第5页 / 共22页
亲,该文档总共22页,到这儿已超出免费预览范围,如果喜欢就下载吧!
资源描述

《YUANDA_CHINA(2789.HK):A_PAINSTAKING_YEAR_OF_REMEDY_AHEAD;_DOWNGRADING_TO_HOLD-2013-04-19.pdf》由会员分享,可在线阅读,更多相关《YUANDA_CHINA(2789.HK):A_PAINSTAKING_YEAR_OF_REMEDY_AHEAD;_DOWNGRADING_TO_HOLD-2013-04-19.pdf(22页珍藏版)》请在三一文库上搜索。

1、Deutsche Bank Markets Research Rating Hold Asia China Industrials Manufacturing Company Yuanda China Date 18 April 2013 Recommendation Change A painstaking year of remedy ahead; downgrading to Hold Reuters Bloomberg Exchange Ticker 2789.HK 2789 HK HKG 2789 Forecasts And Ratios Year End Dec 31 2011A

2、2012A2013E2014E2015E Sales (CNYm) 10,797.0 11,844.612,708.714,108.715,624.7 EBITDA (CNYm) 1,285.7 625.6728.4941.61,135.6 Reported NPAT (CNYm) 850.3 438.5488.6617.8776.9 DB EPS FD(CNY) 0.16 0.070.080.100.13 % Change 0.0% -48.4%-52.3%-50.9%-42.2% DB EPS growth (%) -18.6 -54.711.426.425.8 PER (x) 6.5 1

3、0.57.55.94.7 EV/EBITDA (x) 3.9 6.94.83.93.4 Yield (net) (%) 3.7 5.46.07.69.6 Source: Deutsche Bank estimates, company data Margin recovery tougher than expected - not just cyclicality _ Deutsche Bank AG/Hong Kong Deutsche Bank does and seeks to do business with companies covered in its research repo

4、rts. Thus, investors should be aware that the firm may have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only a single factor in making their investment decision. DISCLOSURES AND ANALYST CERTIFICATIONS ARE LOCATED IN APPENDIX 1. MI

5、CA(P) 054/04/2013. Price at 18 Apr 2013 (HKD) 0.74 Price target - 12mth (HKD) 0.69 52-week range (HKD) 1.07 - 0.64 HANG SENG INDEX 21,570 Vivian Hao Research Analyst (+852) 2203 6241 Key changes Rating Buy to Hold Price target 1.20 to 0.69 -42.5% Sales (FYE) 12,876 to 12,709 -1.3% Op prof margin (F

6、YE) 9.4 to 5.2 -45.0% Net profit (FYE) 901.1 to 488.6 -45.8% Price/price relative 0.4 0.8 1.2 1.6 2.0 5/1111/115/1211/12 Yuanda China HANG SENG INDEX (Rebased) Performance (%) 1m3m12m Absolute -6.3-26.0-30.8 HANG SENG INDEX -2.3-8.63.8 Despite a gradual warm-up of the global construction market, we

7、reduce our top-line and earnings estimates for Yuanda by a big margin on 1) lukewarm new order and backlog growth in light of more conservative corporate growth strategy, 2) continued margin drag and cash collection issue from overseas projects (30% of backlog and revenues in FY12), and 3) managemen

8、ts oversight on project management and risk control. With no signs of a clear margin recovery in the near term and substantial remedial work to be done, we downgrade Yuanda from Buy to Hold and halve our target price to HK$0.69. Lukewarm order book and backlog growth to continue in FY13E We tweak do

9、wn our net revenue marginally by 1.3% for FY13E in light of Yuandas more conservative bidding strategy, which is likely to lead to tepid growth in backlog and new contracts. During FY12, Yuandas backlog/new orders grew by merely 8%/7% YoY in cf. 20%/23% YoY in FY11. We expect only a 4% YoY growth in

10、 new orders and low-mid teen YoY growth in backlog for FY13 with management expecting a strategic pull-back. Earnings growth hurt by continued overseas margin drag We lower our GM forecasts for FY13/14E by 2.7ppt/3.5ppt against a much slower margin recovery outlook while management just started to f

11、ocus on strengthening internal control by 4Q12. We believe Yuandas overseas segment margins (GM 1315%) will continue to be a big drag to the group (GM 16.5% in FY12) due to 1) continuing project duration extension amidst project owner funding issues in the Middle East and Europe, 2) difficulty in ma

12、naging labor-related on-site costs as a foreign contractor. Further, Yuandas NIM was lowered by 3.2ppt/3.9ppt to 3.8%/4.4% for FY13/14E due to higher borrowings needs to fund the near-term working capital requirements. Lower target price to HK$0.69 (almost halved) and downgrade to Hold; risks We set

13、 the new target price at HK$0.69 (previous HK$1.20), based on 7x fwd P/E FY13E (previous 6x P/E FY13E) , which is in line with its current trading P/E and a 15% discount to the China construction peer avg. of 8x, on Yuandas less promising outlook. Downside risks: project-delay-led cost overrun. Upsi

14、de: new orders. 18 April 2013 Manufacturing Yuanda China Page 2 Deutsche Bank AG/Hong Kong Model updated:17 April 2013 Running the numbers Asia China Manufacturing Yuanda China Reuters: 2789.HK Bloomberg: 2789 HK Hold Price (18 Apr 13) HKD 0.74 Target Price HKD 0.69 52 Week range HKD 0.64 - 1.07 Mar

15、ket Cap (m) HKDm 4,037 USDm 520 Company Profile Yuanda China is a leading manufacturer of curtain walls in China. The company provides one-stop solutions for curtain wall systems with a focus on commercial and public facilities. Its main international markets include the United Arab Emirates, UK, Au

16、stralia and USA. Price Performance 0.4 0.8 1.2 1.6 2.0 May 11Aug 11Nov 11Feb 12May 12Aug 12Nov 12Feb 13 Yuanda ChinaHANG SENG INDEX (Rebased) Margin Trends 4 6 8 10 12 14 10111213E14E15E EBITDA MarginEBIT Margin Growth as a result, the recommendations may differ and the price targets and estimates o

17、f each may vary widely. In August 2009, Deutsche Bank instituted a new policy whereby analysts may choose not to set or maintain a target price of certain issuers under coverage with a Hold rating. In particular, this will typically occur for “Hold“ rated stocks having a market cap smaller than most

18、 other companies in its sector or region. We believe that such policy will allow us to make best use of our resources. Please visit our website at http:/ to determine the target price of any stock. The financial instruments discussed in this report may not be suitable for all investors and investors

19、 must make their own informed investment decisions. Stock transactions can lead to losses as a result of price fluctuations and other factors. If a financial instrument is denominated in a currency other than an investors currency, a change in exchange rates may adversely affect the investment. Past

20、 performance is not necessarily indicative of future results. Deutsche Bank may with respect to securities covered by this report, sell to or buy from customers on a principal basis, and consider this report in deciding to trade on a proprietary basis. Unless governing law provides otherwise, all tr

21、ansactions should be executed through the Deutsche Bank entity in the investors home jurisdiction. In the U.S. this report is approved and/or distributed by Deutsche Bank Securities Inc., a member of the NYSE, the NASD, NFA and SIPC. In Germany this report is approved and/or communicated by Deutsche

22、 Bank AG Frankfurt authorized by the BaFin. In the United Kingdom this report is approved and/or communicated by Deutsche Bank AG London, a member of the London Stock Exchange and regulated by the Financial Services Authority for the conduct of investment business in the UK and authorized by the BaF

23、in. This report is distributed in Hong Kong by Deutsche Bank AG, Hong Kong Branch, in Korea by Deutsche Securities Korea Co. This report is distributed in Singapore by Deutsche Bank AG, Singapore Branch or Deutsche Securities Asia Limited, Singapore Branch, and recipients in Singapore of this report

24、 are to contact Deutsche Bank AG, Singapore Branch or Deutsche Securities Asia Limited, Singapore Branch in respect of any matters arising from, or in connection with, this report. Where this report is issued or promulgated in Singapore to a person who is not an accredited investor, expert investor

25、or institutional investor (as defined in the applicable Singapore laws and regulations), Deutsche Bank AG, Singapore Branch or Deutsche Securities Asia Limited, Singapore Branch accepts legal responsibility to such person for the contents of this report. In Japan this report is approved and/or distr

26、ibuted by Deutsche Securities Inc. The information contained in this report does not constitute the provision of investment advice. In Australia, retail clients should obtain a copy of a Product Disclosure Statement (PDS) relating to any financial product referred to in this report and consider the

27、PDS before making any decision about whether to acquire the product. Deutsche Bank AG Johannesburg is incorporated in the Federal Republic of Germany (Branch Register Number in South Africa: 1998/003298/10). Additional information relative to securities, other financial products or issuers discussed in this report is available upon request. This report may not be reproduced, distributed or published by any person for any purpose without Deutsche Banks prior written consent. Please cite source when quoting. Copyright 2013 Deutsche Bank AG

展开阅读全文
相关资源
猜你喜欢
相关搜索

当前位置:首页 > 其他


经营许可证编号:宁ICP备18001539号-1